Clinical Trial Update: Open Label of Clinical Trial of Sulforaphane in Children With Autism [Phase 3]

View source ↗

Summary

Open-label phase 3 clinical trial of sulforaphane in children with autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: University of California, San Francisco | Conditions: Autism | Phase 3 | Status: COMPLETED